Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25899144 | 0.78 | POLB (0.30) | POLB | |
| SCHEMBL22702293 | 0.72 | CRBN (0.44) | POLBLMNAGAA | |
| SCHEMBL1188908 | 0.72 | CRBN (0.44) | POLBLMNAGAA | |
| SCHEMBL3668437 | 0.72 | CRBN (0.44) | POLBLMNAGAA | |
| SCHEMBL24349137 | 0.69 | POLB (0.35) | POLB | |
| SCHEMBL24391153 | 0.68 | MAPT (0.33) | POLBLMNAGAA | |
| SCHEMBL24391155 | 0.68 | MAPT (0.33) | POLBLMNAGAA | |
| SCHEMBL3877149 | 0.67 | CRBN (0.48) | POLBLMNA | |
| SCHEMBL24322549 | 0.67 | LMNA (0.37) | LMNA | |
| SCHEMBL8827117 | 0.67 | KMT2A (0.34) | POLBLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226214-A1 | BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION | LYCIA THERAPEUTICS, INC. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226214-A1 | BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION | HAVCR2, FCGR3B, FCGR2A | POLB 1097/4885LMNA 2681/4885GAA 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.